Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ABP 980|DRUG: Trastuzumab|DRUG: Paclitaxel|PROCEDURE: Lumpectomy or Mastectomy with Sentinel Node or Axillary Node Dissection
Sponsor: Amgen
Collaborators: Actavis Inc.